Praxis Precision Medicines, Inc. · NASDAQ:PRAX
Sniecinski Megan received 89 Praxis Precision Medicines, Inc. shares as an award (Form 4)
Traded May 14, 2026 · Filed May 19, 2026
On May 14, 2026, Sniecinski Megan (Chief Operating Officer) received 89 Praxis Precision Medicines, Inc. shares as an award at US$167.94 for US$14,947, leaving 28,664 shares. Filed May 19, 2026 (Form 4).
- Awarded
- 89 shares
- Price
- US$167.94
- Value
- US$14,947
- Holding after
- 28,664 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | Award | 89 | US$167.94 | 28,664 | Direct |
Source
Related
- Praxis Precision Medicines, Inc.
- Sniecinski Megan
- Praxis Precision Medicines, Inc. shareholders
- Schedule 13G/A · Orbis Investment Management LTD · Aug 14, 2026
- Form 4 · Souza Marcio · Jul 8, 2026
- Form 4 · DeSimone Jill · Jun 26, 2026
- Form 4 · Arbuckle Stuart A · Jun 12, 2026
- Form 4 · Chodakewitz Jeffrey · Jun 12, 2026